Resveratrol provides neuroprotection by inhibiting phosphodiesterases and regulating the cAMP/AMPK/SIRT1 pathway after stroke in rats
- 1 March 2016
- journal article
- Published by Elsevier BV in Brain Research Bulletin
- Vol. 121, 255-262
- https://doi.org/10.1016/j.brainresbull.2016.02.011
Abstract
No abstract availableKeywords
Funding Information
- Foundation for Science and Technology Research Project of Chongqing (cstc2012ggB1002)
This publication has 40 references indexed in Scilit:
- Granulocyte-colony stimulating factor activates JAK2/PI3K/PDE3B pathway to inhibit corticosterone synthesis in a neonatal hypoxic-ischemic brain injury rat modelExperimental Neurology, 2015
- Metabolic benefits of inhibiting cAMP-PDEs with resveratrolAdipocyte, 2012
- Anti‐inflammatory effects of resveratrol: possible role in prevention of age‐related cardiovascular diseaseAnnals of the New York Academy of Sciences, 2011
- The SIRT1 activator resveratrol protects SK‐N‐BE cells from oxidative stress and against toxicity caused by α‐synuclein or amyloid‐β (1‐42) peptideJournal of Neurochemistry, 2009
- StrokeThe Lancet, 2008
- Resveratrol stimulates AMP kinase activity in neuronsProceedings of the National Academy of Sciences of the United States of America, 2007
- Resveratrol improves health and survival of mice on a high-calorie dietNature, 2006
- Mechanism of Human SIRT1 Activation by ResveratrolJournal of Biological Chemistry, 2005
- The Sir2 Family of Protein DeacetylasesAnnual Review of Biochemistry, 2004
- Temporary middle cerebral artery occlusion in the rat: consistent protocol for a model of stroke and reperfusionNeuropathology and Applied Neurobiology, 2000